- ... GRADE evidence profile: What are the most effective adjuvant intravesical therapy (chemotherapy or immunotherapy) ... Table 33 GRADE evidence profile: What ...
- ... or 4 worst overall toxicities H.14.10. Adjuvant immunotherapy versus no adjuvant therapy in resected pancreatic cancer patients Figure 406 ...
- ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ...
- ... relevant to PICO. Davar D, Tarhini, et al. Adjuvant immunotherapy of melanoma and development of new approaches using ...
- ... for the StatRoc study (A Feasibility Study of Adjuvant Statin Therapy in the Prevention of Post-Operative Recurrence of Oesophageal Adenocarcinoma). Funded by NIHR. No ...
- ... Goodwin A, Parker S, Ghersi D, et al.: Post-operative radiotherapy for ductal carcinoma ... National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions ...
- ... or double intravesical epirubicin instillation in the early postoperative period to prevent ... A, et al. Adjuvant chemotherapy with early intravesical instillation of adriamycin and ...
- ... IV glioma Figure 27 RT with concomitant and adjuvant TMZ versus RT alone: overall survival – subgroup differences ... IV glioma Figure 28 RT with concomitant and adjuvant TMZ versus RT alone: overall survival – subgroup differences ...
- ... neuroendocrine differentiation are more responsive to chemotherapy.[ 66 ] Immunotherapy Sipuleucel-T, an active cellular immunotherapy, has been ... et al.: Results of local and/or systemic adjuvant therapy in the management of pathological stage C ...
- ... V. Ketoprofen and pethidine in the treatment of post-operative pain following synovectomy. A double-blind trial on ... double-blind prospective randomized study. International journal of immunotherapy. 2001;17(2):135–41. Exclusion: 6 904. ...
14 results